Voyager Therapeutics, Inc.

NasdaqGS:VYGR Stock Report

Market Cap: US$326.7m

Voyager Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:VYGR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Oct 24SellUS$34,914Jacquelyn SandellIndividual5,999US$5.82
02 Apr 24SellUS$13,407Robin SwartzIndividual1,357US$9.88
02 Apr 24SellUS$119,454Alfred SandrockIndividual12,115US$9.86
21 Feb 24SellUS$28,079Peter PfreundschuhIndividual3,764US$7.46
21 Feb 24SellUS$97,226Alfred SandrockIndividual13,033US$7.46
21 Feb 24SellUS$29,760Todd CarterIndividual3,967US$7.68
21 Feb 24SellUS$29,547Robin SwartzIndividual3,966US$7.45
17 Jan 24SellUS$9,090Todd CarterIndividual1,266US$7.18
17 Jan 24SellUS$18,182Robin SwartzIndividual2,543US$7.15

Insider Trading Volume

Insider Buying: VYGR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of VYGR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders589,9351.08%
General Public7,544,08713.8%
Public Companies8,575,31615.7%
Hedge Funds9,117,54616.7%
Institutions28,706,37052.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.2%.


Top Shareholders

Top 25 shareholders own 74.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
Neurocrine Biosciences, Inc.
8,575,316US$51.4m0%no data
10%
BlackRock, Inc.
5,459,941US$32.7m2.77%no data
9.54%
Armistice Capital LLC
5,200,000US$31.1m11.3%0.76%
7.18%
EcoR1 Capital, LLC
3,917,546US$23.5m0%0.73%
5.57%
The Vanguard Group, Inc.
3,038,564US$18.2m-5.98%no data
4.2%
Farallon Capital Management, L.L.C.
2,292,000US$13.7m0%0.08%
3.28%
State Street Global Advisors, Inc.
1,789,189US$10.7m2.29%no data
2.94%
Great Point Partners, LLC
1,601,527US$9.6m0%1.78%
1.97%
Geode Capital Management, LLC
1,072,769US$6.4m10.3%no data
1.87%
American Century Investment Management Inc
1,019,332US$6.1m32.4%no data
1.81%
T. Rowe Price Group, Inc.
989,549US$5.9m-5.03%no data
1.49%
Dimensional Fund Advisors LP
813,680US$4.9m-26.4%no data
1.19%
Bank of America Corporation, Asset Management Arm
648,535US$3.9m83%no data
1.1%
Vestal Point Capital, LP
600,000US$3.6m0%0.24%
1.02%
Federated Hermes, Inc.
554,214US$3.3m0.48%0.01%
0.92%
AQR Capital Management, LLC
501,911US$3.0m-36.7%no data
0.8%
Morgan Stanley, Investment Banking and Brokerage Investments
437,034US$2.6m88.5%no data
0.69%
Northern Trust Global Investments
374,161US$2.2m-4.02%no data
0.6%
Goldman Sachs Group, Investment Banking and Securities Investments
324,930US$1.9m18.4%no data
0.55%
Woodline Partners LP
300,000US$1.8m0%0.02%
0.54%
BNY Asset Management
294,420US$1.8m17.7%no data
0.53%
GlobeFlex Capital LP
291,293US$1.7m-5.89%0.12%
0.48%
Fiduciary Trust Company
259,397US$1.6m0%0.02%
0.46%
JP Morgan Asset Management
249,369US$1.5m-13.7%no data
0.45%
Wellington Management Group LLP
246,992US$1.5m21.1%no data